Wholesale · For professional use only Quote on request ENRU
Nabota 200U

Nabota 200U

Nabota 200U is a Type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and approved by the United States Food and Drug Administration (FDA). As the first Korean botulinum toxin to enter the American market, Nabota competes directly with Botox as a cost-effective alternative that does not require changing the way this potentially toxic substance is handled.

Active Ingredient

Clostridium Type A botulinum toxin (strain: Clostridium Botulinum CBFC26)

Units

200 units

Packaging

1 vial of 200 units per box

Wholesale price $108.00

Description

The Type A botulinum toxin Nabota is used to combat the appearance of wrinkles that develop due to uncontrolled muscle tone in the face and active facial expressions. Nabota is a proven, safe and reliable product, developed by Daewoong Pharmaceutical Co., Ltd., South Korea, with more than 30 years of experience in biotechnology.
  • Rapid action
  • High standard of cleanliness
  • Long-lasting effects
  • It does not “freeze” facial expressions
  • High safety

Application Areas

  • Smoothing of wrinkles in the eyebrow region, nasolabial folds, wrinkles around the eyes and mouth, periorbital areas
  • Elimination of blepharospasm
  • Elimination of hyperhidrosis
  • Lifting with Botox
Active IngredientClostridium Type A botulinum toxin (strain: Clostridium Botulinum CBFC26)
Units200 units
Packaging1 vial of 200 units per box

Recommended Archive